Startup Directory
Top Biotech Startups in India - 2026
Last updated: · 9+ companies
Biotech startups in India are easier to evaluate when company discovery is tied to founder profiles, funding signals, and adjacent newsroom context. This page is built to help readers compare companies working on high-intent category workflows without relying on thin list pages. Companies such as category-defining startups show how quickly the category can move when product depth and distribution align. In 2026, buyers and investors are prioritizing cleaner execution signals than before. That makes this directory useful for founders, investors, operators, and buyers who want faster startup research with cleaner context.
NNewLimit
Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare
Last round: Series B Founders Fund, $130M Series B in 2025
RTROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals
Last round: Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation
HFHoxton Farms
Grow real animal fat without the animals for delicious, cruelty-free, sustainable ingredient Biotech Sustainability
Last round: Series A Founders Fund, $22M Series A in 2022
KKernel
Kernel is a neuroscience company that specializes in developing brain-recording technologies. Biotech Life Science
Last round: Series C Khosla Ventures, $153M Series C in 2020
SSynchron
Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware
Last round: Series C Khosla Ventures, $75M Series C in 2022
CLClear Labs
Clear Labs is a provider of a fully-automated sequencing platform for turnkey diagnostics. Biotech Healthcare Robotics Hardware
Last round: Series C Khosla Ventures, $58M Series C in 2020
BLBioAge Labs
BIOAGE targets aging to develop drugs that treat severe diseases Biotech
Last round: Series D Andreessen Horowitz, $170M Series D in 2024
KKarius
Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare
Last round: Series B Khosla Ventures, $165M Series B in 2020
CTCAMP4 Therapeutics
BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech
Last round: Series B Andreessen Horowitz, $100M Series B in 2022
Related Startup Pages
Connected Pillar Routes
Continue discovery through country, industry, stage, funding, and newsroom hubs.
Explore Biotech Startups By Market and Investor
Use adjacent hub routes to move from category discovery into city-level clusters and investor-backed startup cohorts.
Top City Hubs
Frequently Asked Questions
Practical questions readers ask before comparing companies, founders, and market momentum.
What does this biotech page track?
It tracks startups associated with biotech, along with linked founder profiles and related market context on 100Xfounder.
Why is biotech important in 2026?
Because buyers and investors are prioritizing cleaner execution signals than before.
Can I use this page for founder research?
Yes. Each company route connects discovery to deeper founder and company-level validation.
How should investors compare these startups?
Use founder quality, category positioning, and current funding context instead of relying on headlines alone.
Is this page only for Indian companies?
It is optimized for India-focused discovery, while still supporting cross-border research where relevant.